Developer docs
API playgroundTry for free, no card

Search company profiles

Uromedtech

Full company profile

uuid00qzs3h

Namestring
Uromedtech
Legal namestring
UroMedTech Pte. Ltd.
Websiteurl
uromedtech.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

UroMedTech Pte. Ltd. is a Singapore-based privately held medical technology company founded to develop urological diagnostic and procedural devices. Its core product is the UroMaster Adventure, a robot-guided MRI-ultrasound fusion biopsy system for precision transperineal prostate biopsy, comprising three integrated components: the Uro-Matic ultrasound workstation, the AccuBot transperineal robotic assistance system, and the UroPro MRI-ultrasound fusion software. The system uses AI-powered One-Click Auto-Segmentation and Auto-Registration functions and sub-millimeter robotic needle positioning with an adjustable insertion angle of plus or minus 30 degrees to reduce false negative biopsies and eliminate sepsis risk associated with transrectal approaches.

The company operates a hardware-led revenue model, selling capital equipment directly to hospital urology departments through enterprise field sales supplemented by live demonstration cases and on-site training. Its portfolio also includes the BVS-Pro wireless portable 3D ultrasound bladder scanner (with EHR/EPD integration via DICOM and HL7) and the S-MM-2.3 Multi Modality Prostate Phantom for clinical training, both distributed under exclusive regional agreements. Marketing is concentrated on a corporate website, LinkedIn presence, scientific publication citations, and press announcements.

As of January 2025, UroMedTech's commercial footprint is limited to Singapore and Malaysia, with the IUN at General Hospital Kuala Lumpur serving as its flagship regional reference site. The company is founder/management-owned with no disclosed institutional funding, external investors, or regulatory clearances (e.g., FDA 510(k), CE Mark) referenced in available sources.

Short descriptiontext

UroMedTech Pte. Ltd. is a Singapore-based privately held medical technology company that develops and sells the UroMaster Adventure robot-guided MRI-ultrasound fusion biopsy system, BVS-Pro bladder scanner, and prostate training phantoms to hospital urology departments in Singapore and Malaysia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
MRI-US fusion biopsy, prostate cancer diagnostics, urology medical devices, robot-guided biopsy, bladder volume scanning
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAOAF
Endourology & Minimally Invasive Urologic Surgery
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKAOAB
Urologic Oncology
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Urology Medical Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of urological medical devices including the UroMaster Adventure MRI-US Fusion Biopsy System, BVS-Pro Ultrasound Bladder Scanner, and Prostate Phantom training models to hospitals and healthcare institutions

uromedtech.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1UroMaster Adventure
Description

Robot-guided MRI-US Fusion Biopsy System for prostate cancer diagnostics with AI-powered auto-segmentation and auto-registration functions.

uromedtech.com
+5 more records
Core offering1 text field

UroMedTech develops and sells urological medical devices, primarily the UroMaster Adventure robot-guided MRI-US Fusion Biopsy System for precision transperineal prostate biopsy. The company also distributes the BVS-Pro wireless 3D ultrasound bladder volume scanner and the S-MM-2.3 multi-modality prostate phantom for medical training. All products are targeted at hospitals, urology departments, and medical training institutions for improved diagnostic accuracy in prostate cancer detection and urological care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Significantly upgrades prostate cancer detection compared to systematic 12-core transrectal ultrasound biopsy (based on published clinical studies)
+1 more record
Product overview1 text field

Uromedtech offers a portfolio of urological medical devices centered on the UroMaster Adventure system, an MRI-US Fusion Prostate Biopsy System. The UroMaster Adventure consists of three integrated components: the Uro-Matic Ultrasound Workstation, the AccuBot Transperineal Robotic Assistance System, and the UroPro MRI-Ultrasound Fusion Software. Additionally, the company distributes the BVS-Pro, a wireless 3D ultrasound bladder volume scanner, and the S-MM-2.3 Multi Modality Prostate Phantom Model for medical training. These products address prostate cancer diagnostics, bladder assessment, and medical procedure training.

Product and service3 records
1UroMaster Adventure
CategoryUrology Medical Devices
Description

A robot-guided MRI-US Fusion Biopsy System designed for precision transperineal prostate biopsy, combining real-time ultrasound imaging with MRI fusion and robotic assistance for accurate tissue sampling. Targeted at hospital urology departments and urologists performing prostate cancer diagnostics.

2BVS-Pro
CategoryUrology Medical Devices
Description

A wireless, portable 3D ultrasound bladder volume scanner with automatic gender selection, rechargeable battery, and smartphone/tablet connectivity. Designed for diagnosis and treatment of urological conditions including bladder volume measurement and urinary retention assessment. Targeted at healthcare professionals and mobile healthcare workers.

3S-MM-2.3 Multi Modality Prostate Phantom Model
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1National Institute of Urology and Nephrology (IUN) at General Hospital Kuala Lumpur
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

UroMedTech partnered with Malaysia's National Institute of Urology and Nephrology (IUN) at General Hospital Kuala Lumpur for live demonstration cases of the UroMaster Adventure system. The institute is a national centre of urology offering specialized training and equipped with state-of-the-art facilities and advanced operating theatres. The partnership enables UroMedTech to demonstrate its robotic prostate fusion biopsy technology to urology experts in the region.

uromedtech.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

French developer of MRI/TRUS fusion biopsy systems for prostate cancer, including the Trinity and OASIS platforms. Direct competitor offering image-guided, fusion-based prostate biopsy workflows to urology departments in hospitals globally.

TypeEmerging player
Description

Developer of image-guided high-intensity focused ultrasound (HIFU) systems for prostate tissue ablation. Emerging player with partial overlap in the image-guided urology intervention space that UroMedTech's robotic platform could expand into via adjacent indications.

TypeBroad incumbent
Description

Specialist in urology and interventional ultrasound, now part of GE Healthcare. Provides ultrasound platforms widely used in prostate biopsy and fusion workflows, making it a broad incumbent competing for the same hospital urology capital budget.

TypeBroad incumbent
Description

Italian manufacturer of diagnostic ultrasound systems, including specialty transducers and platforms used in urology and prostate imaging. Broad incumbent offering overlapping hardware used in fusion and ultrasound-guided prostate biopsy workflows.

5MedCom
TypeDirect peer
Description

German developer of image registration and fusion software (e.g., BioFusion) used in MRI-US fusion biopsy and other image-guided interventions. Direct software peer competing in the fusion workflow layer that UroMedTech's UroPro software addresses.

TypeDirect peer
Description

Singapore-based developer of the iSR'obot Mona Lisa, a robotic transperineal prostate biopsy system. Direct peer in robot-guided transperineal biopsy targeting the same hospital urology customer base as UroMaster Adventure, with regional Asian distribution.

TypeBroad incumbent
Description

Philips offers UroNav, an MRI-ultrasound fusion platform for targeted prostate biopsy, integrated with its broader imaging and interventional portfolio. Operates as a broad incumbent with global hospital reach and deep KOL networks that compete with UroMedTech's fusion positioning.

8MIM Software
TypeEmerging player
Description

Specialist in medical imaging analysis and fusion software used across radiology, oncology, and image-guided interventions. Emerging player with partial overlap to UroMedTech's UroPro fusion software capabilities in prostate biopsy and image-guided therapy.

TypeBroad incumbent
Description

Offers diagnostic ultrasound and real-time tissue elastography systems used for prostate imaging and biopsy guidance. Operates as a broad incumbent with global installed bases and competes for the same urology capital purchasing slots.

TypeDirect peer
Description

Developer of the Artemis MRI-US fusion biopsy system, now part of GE Healthcare. Direct competitor in prostate fusion biopsy with FDA-cleared hardware and software used in hospital urology practices worldwide.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Uromedtech

Urology Medical Devicesuromedtech.com

UroMedTech Pte. Ltd. is a Singapore-based privately held medical technology company that develops and sells the UroMaster Adventure robot-guided MRI-ultrasound fusion biopsy system, BVS-Pro bladder scanner, and prostate training phantoms to hospital urology departments in Singapore and Malaysia.

What Uromedtech does

UroMedTech Pte. Ltd. is a Singapore-based privately held medical technology company founded to develop urological diagnostic and procedural devices. Its core product is the UroMaster Adventure, a robot-guided MRI-ultrasound fusion biopsy system for precision transperineal prostate biopsy, comprising three integrated components: the Uro-Matic ultrasound workstation, the AccuBot transperineal robotic assistance system, and the UroPro MRI-ultrasound fusion software. The system uses AI-powered One-Click Auto-Segmentation and Auto-Registration functions and sub-millimeter robotic needle positioning with an adjustable insertion angle of plus or minus 30 degrees to reduce false negative biopsies and eliminate sepsis risk associated with transrectal approaches.

The company operates a hardware-led revenue model, selling capital equipment directly to hospital urology departments through enterprise field sales supplemented by live demonstration cases and on-site training. Its portfolio also includes the BVS-Pro wireless portable 3D ultrasound bladder scanner (with EHR/EPD integration via DICOM and HL7) and the S-MM-2.3 Multi Modality Prostate Phantom for clinical training, both distributed under exclusive regional agreements. Marketing is concentrated on a corporate website, LinkedIn presence, scientific publication citations, and press announcements.

As of January 2025, UroMedTech's commercial footprint is limited to Singapore and Malaysia, with the IUN at General Hospital Kuala Lumpur serving as its flagship regional reference site. The company is founder/management-owned with no disclosed institutional funding, external investors, or regulatory clearances (e.g., FDA 510(k), CE Mark) referenced in available sources.

Uromedtech firmographics

Firmographics
Name
Uromedtech
Legal name
UroMedTech Pte. Ltd.
Website
https://uromedtech.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
UroMedTech Pte. Ltd. is a Singapore-based privately held medical technology company that develops and sells the UroMaster Adventure robot-guided MRI-ultrasound fusion biopsy system, BVS-Pro bladder scanner, and prostate training phantoms to hospital urology departments in Singapore and Malaysia.
Ownership category
akta.pro rank

Uromedtech industry classification

Industry
Product category
Urology Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAOAF
Endourology & Minimally Invasive Urologic Surgery
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKAOAB
Urologic Oncology

Keywords

  • MRI-US fusion biopsy
  • Prostate cancer diagnostics
  • Urology medical devices
  • Robot-guided biopsy
  • Bladder volume scanning

Where Uromedtech is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices1 record

Markets served

Uromedtech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Hardware Sales: Sale of urological medical devices including the UroMaster Adventure MRI-US Fusion Biopsy System, BVS-Pro Ultrasound Bladder Scanner, and Prostate Phantom training models to hospitals and healthcare institutions

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Uromedtech product offering

Product offering

Core offering

UroMedTech develops and sells urological medical devices, primarily the UroMaster Adventure robot-guided MRI-US Fusion Biopsy System for precision transperineal prostate biopsy. The company also distributes the BVS-Pro wireless 3D ultrasound bladder volume scanner and the S-MM-2.3 multi-modality prostate phantom for medical training. All products are targeted at hospitals, urology departments, and medical training institutions for improved diagnostic accuracy in prostate cancer detection and urological care.

Product overview

Uromedtech offers a portfolio of urological medical devices centered on the UroMaster Adventure system, an MRI-US Fusion Prostate Biopsy System. The UroMaster Adventure consists of three integrated components: the Uro-Matic Ultrasound Workstation, the AccuBot Transperineal Robotic Assistance System, and the UroPro MRI-Ultrasound Fusion Software. Additionally, the company distributes the BVS-Pro, a wireless 3D ultrasound bladder volume scanner, and the S-MM-2.3 Multi Modality Prostate Phantom Model for medical training. These products address prostate cancer diagnostics, bladder assessment, and medical procedure training.

Differentiator

Problem solved

Functional benefit

Brands

  • UroMaster Adventure: Robot-guided MRI-US Fusion Biopsy System for prostate cancer diagnostics with AI-powered auto-segmentation and auto-registration functions.
  • BVS-Pro
  • S-MM-2.3 Prostate Phantom
  • Uro-Matic Ultrasound Workstation
  • AccuBot Transperineal Robotic Assistance System
  • UroPro MRI-Ultrasound Fusion Software

Products and services

  • UroMaster Adventure A robot-guided MRI-US Fusion Biopsy System designed for precision transperineal prostate biopsy, combining real-time ultrasound imaging with MRI fusion and robotic assistance for accurate tissue sampling. Targeted at hospital urology departments and urologists performing prostate cancer diagnostics.
  • BVS-Pro A wireless, portable 3D ultrasound bladder volume scanner with automatic gender selection, rechargeable battery, and smartphone/tablet connectivity. Designed for diagnosis and treatment of urological conditions including bladder volume measurement and urinary retention assessment. Targeted at healthcare professionals and mobile healthcare workers.
  • S-MM-2.3 Multi Modality Prostate Phantom Model

Quantifiable outcome

  • Significantly upgrades prostate cancer detection compared to systematic 12-core transrectal ultrasound biopsy (based on published clinical studies)
  • +1 more outcomes

Companies that use Uromedtech

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Uromedtech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature7 records

Uromedtech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • National Institute of Urology and Nephrology (IUN) at General Hospital Kuala LumpurcoreStrategic or Co-development Partner · 1 January 2025UroMedTech partnered with Malaysia's National Institute of Urology and Nephrology (IUN) at General Hospital Kuala Lumpur for live demonstration cases of the UroMaster Adventure system. The institute is a national centre of urology offering specialized training and equipped with state-of-the-art facilities and advanced operating theatres. The partnership enables UroMedTech to demonstrate its robotic prostate fusion biopsy technology to urology experts in the region.

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Uromedtech competitors and assessment

Company assessment

Direct peers

  • Koelis: French developer of MRI/TRUS fusion biopsy systems for prostate cancer, including the Trinity and OASIS platforms. Direct competitor offering image-guided, fusion-based prostate biopsy workflows to urology departments in hospitals globally.
  • MedCom: German developer of image registration and fusion software (e.g., BioFusion) used in MRI-US fusion biopsy and other image-guided interventions. Direct software peer competing in the fusion workflow layer that UroMedTech's UroPro software addresses.
  • Biobot Surgical: Singapore-based developer of the iSR'obot Mona Lisa, a robotic transperineal prostate biopsy system. Direct peer in robot-guided transperineal biopsy targeting the same hospital urology customer base as UroMaster Adventure, with regional Asian distribution.
  • Eigen (GE Healthcare): Developer of the Artemis MRI-US fusion biopsy system, now part of GE Healthcare. Direct competitor in prostate fusion biopsy with FDA-cleared hardware and software used in hospital urology practices worldwide.

Emerging players

  • SonaCare Medical: Developer of image-guided high-intensity focused ultrasound (HIFU) systems for prostate tissue ablation. Emerging player with partial overlap in the image-guided urology intervention space that UroMedTech's robotic platform could expand into via adjacent indications.
  • MIM Software: Specialist in medical imaging analysis and fusion software used across radiology, oncology, and image-guided interventions. Emerging player with partial overlap to UroMedTech's UroPro fusion software capabilities in prostate biopsy and image-guided therapy.

Broad incumbents

  • BK Medical (GE Healthcare): Specialist in urology and interventional ultrasound, now part of GE Healthcare. Provides ultrasound platforms widely used in prostate biopsy and fusion workflows, making it a broad incumbent competing for the same hospital urology capital budget.
  • Esaote: Italian manufacturer of diagnostic ultrasound systems, including specialty transducers and platforms used in urology and prostate imaging. Broad incumbent offering overlapping hardware used in fusion and ultrasound-guided prostate biopsy workflows.
  • Philips (UroNav): Philips offers UroNav, an MRI-ultrasound fusion platform for targeted prostate biopsy, integrated with its broader imaging and interventional portfolio. Operates as a broad incumbent with global hospital reach and deep KOL networks that compete with UroMedTech's fusion positioning.
  • Hitachi / FUJIFILM Healthcare: Offers diagnostic ultrasound and real-time tissue elastography systems used for prostate imaging and biopsy guidance. Operates as a broad incumbent with global installed bases and competes for the same urology capital purchasing slots.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Uromedtech social profiles

Digital presence

Uromedtech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Uromedtech leadership team

Management profile

Number of profiles

Uromedtech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Uromedtech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uromedtech

What does Uromedtech do?

UroMedTech develops and sells urological medical devices, primarily the UroMaster Adventure robot-guided MRI-US Fusion Biopsy System for precision transperineal prostate biopsy. The company also distributes the BVS-Pro wireless 3D ultrasound bladder volume scanner and the S-MM-2.3 multi-modality prostate phantom for medical training. All products are targeted at hospitals, urology departments, and medical training institutions for improved diagnostic accuracy in prostate cancer detection and urological care.

Is Uromedtech a public or private company?

Uromedtech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Uromedtech founded?

Uromedtech was founded in 2023. It employs 11 to 50 people.

Where is Uromedtech based?

Uromedtech is headquartered in Singapore, Singapore, in the Asia region.

How does Uromedtech make money?

One revenue line is on record: medical Device Hardware Sales.

Who are Uromedtech's main competitors?

Direct peers on record are Koelis, MedCom, Biobot Surgical and Eigen (GE Healthcare). Emerging players are SonaCare Medical and MIM Software. Broad incumbents are BK Medical (GE Healthcare), Esaote, Philips (UroNav) and Hitachi / FUJIFILM Healthcare.

Does Uromedtech have an API?

No public API is recorded for Uromedtech.

What industry is Uromedtech in?

Uromedtech's product category is Urology Medical Devices. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAKAOAF, Endourology & Minimally Invasive Urologic Surgery. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals